Immunomodulatory effects of levamisole. 1980

C J Brunner, and C C Muscoplat

The conditions under which the anthelmintic drug levamisole modulates immune function were reviewed. Treatment with the drug corrects defective leukocyte reactivity and can bring clinical improvement in chronic infections, inflammatory disease, and malignancy. Therapeutic effectiveness depends upon dose, timing, and the patient's immune status, and results are often inconsistent. Levamisole therapy can cause marked but reversible complications, many of which have immunopathologic features.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007978 Levamisole An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) L-Tetramisole,Levotetramisole,Decaris,Dekaris,Levamisole Hydrochloride,Solaskil,Hydrochloride, Levamisole
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000820 Animal Diseases Diseases that occur in VERTEBRATE animals. Diseases, Animal

Related Publications

C J Brunner, and C C Muscoplat
January 1991, International journal of immunopharmacology,
C J Brunner, and C C Muscoplat
December 2005, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
C J Brunner, and C C Muscoplat
December 2023, Journal of advanced veterinary and animal research,
C J Brunner, and C C Muscoplat
January 1986, Indian journal of medical sciences,
C J Brunner, and C C Muscoplat
January 2000, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases,
C J Brunner, and C C Muscoplat
October 2012, Pakistan journal of biological sciences : PJBS,
C J Brunner, and C C Muscoplat
March 1989, Journal of periodontology,
Copied contents to your clipboard!